Off-Target Effects of Recombinant Zoster Vaccine: Clinical Benefits, AS01B Adjuvant Immunobiology, and Observational Evidence.

Tang J, Balaji S, Oon HH

Open source

DOI
10.3390/vaccines14100879
Published
2026 Oct 3
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14100879,
  title = {Off-Target Effects of Recombinant Zoster Vaccine: Clinical Benefits, AS01B Adjuvant Immunobiology, and Observational Evidence.},
  author = {Tang J and Balaji S and Oon HH},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14100879},
  url = {https://doi.org/10.3390/vaccines14100879}
}

RIS

TY  - JOUR
TI  - Off-Target Effects of Recombinant Zoster Vaccine: Clinical Benefits, AS01B Adjuvant Immunobiology, and Observational Evidence.
AU  - Tang J
AU  - Balaji S
AU  - Oon HH
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14100879
UR  - https://doi.org/10.3390/vaccines14100879
ER  - 

APA

J, T., S, B., & HH, O. (2026). Off-Target Effects of Recombinant Zoster Vaccine: Clinical Benefits, AS01B Adjuvant Immunobiology, and Observational Evidence.. Vaccines. https://doi.org/10.3390/vaccines14100879

Source records